Prevention of Ventricular Arrhythmia and Sudden Cardiac Death in COVID-19 Patients

Keyphrases

• Sudden Cardiac Death 100%
• Ventricular Arrhythmia 100%
• COVID-19 100%
• COVID-19 Patients 100%
• Arrhythmias Cardiac 100%
• Azithromycin 66%
• Hydroxychloroquine 66%
• Indonesian 33%
• Virus 33%
• Public Health 33%
• Cardiovascular Risk 33%
• Adverse Effects 33%
• Chloroquine 33%
• Infection Prevention 33%
• Acute Coronary Syndrome 33%
• Clinical Practice Guidelines 33%
• Vascular Inflammation 33%
• Heart Failure 33%
• Treatment Effect 33%
• Viral Infection 33%
• Arrhythmia 33%
• Antiviral Treatment 33%
• High Transmission Rate 33%
• Concurrent Use 33%
• Raising Concerns 33%
• Arrhythmic Death 33%
• Individual Use 33%
• Systemic Inflammatory Response 33%
• Arterial Plaque 33%
• QT Interval 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chloroquine 100%
• Sudden Cardiac Death 100%
• Azithromycin 100%
• Heart Ventricle Arrhythmia 100%
• Infection 50%
• Antivirus Agent 50%
• Virus Infection 50%
• Inflammation 50%
• Cardiovascular Risk 50%
• Vasculitis 50%
• Congestive Heart Failure 50%
• Acute Coronary Syndrome 50%
• Heart Arrhythmia 50%
• Hydroxychloroquine 50%

Medicine and Dentistry

• Sudden Cardiac Death 100%
• Heart Ventricle Arrhythmia 100%
• COVID-19 100%
• Azithromycin 50%
• Chloroquine 50%
• Infection 25%
• Public Health 25%
• Cardiac Dysrhythmia 25%
• Cardiovascular Risk 25%
• Vasculitis 25%
• Congestive Heart Failure 25%
• Virus Infection 25%
• Serositis 25%
• Antiviral Therapy 25%
• QT Interval 25%
• Hydroxychloroquine 25%
• Virus 25%
• Adverse Effect 25%
• Acute Coronary Syndrome 25%